BNST GluN2D-containing NMDARs contribute to ethanol intake but not negative affective behaviors in female mice
Marie A. DoyleiD, Gregory J. SalimandoiD, Megan E. Altemus, Justin K. Badt, Michelle N. BedenbaughiD, Alexander S. Vardy, Danielle N. AdankiD, Anika S. Park, Danny G. WinderiD
Abstract
Alcohol use disorder (AUD) is a chronic, relapsing disease, highly comorbid with anxiety and depression. The bed nucleus of the stria terminalis (BNST), and Crh+ neurons in this region are thought to play a key role in chronic ethanol-induced increases in volitional ethanol intake. This role has been hypothesized to be driven by emergent BNST-dependent negative affective behaviors. Indeed, we report here that in female mice undergoing a home cage chronic drinking forced abstinence model (CDFA), excitatory transmission undergoes time-dependent upregulation in BNST Crh+ cells. Excitatory NMDA receptors (NMDARs) are a major target of ethanol, and chronic ethanol exposure has been shown to regulate NMDAR function and expression. GluN2D subunit-containing NMDARs have emerged as a target of interest due to their limited distribution and potential roles in affective behavior. We find that knockdown of dorsal BNST (dBNST) GluN2D expression significantly decreases ethanol intake in female, but not male, mice. While BNST Grin2b expression was significantly increased in protracted abstinence following CDFA, no differences in Grin2d expression were observed in dBNST or specifically in dBNST Crh+ neurons. Finally, to determine the impact of GluN2D expression on negative affective behaviors, open field, elevated zero maze, and forced swim tasks were used to measure anxiety- and depressive-like behaviors in constitutive and conditional BNST GluN2D knockout mice. Surprisingly, we find that deletion of GluN2D fails to alter negative affect in ethanol-naive female mice. Together, these data suggest a role for BNST GluN2D-containing NMDARs in ethanol drinking behaviors but not abstinence from ethanol, highlighting potential sex differences and behavioral specificity in the context of AUD behaviors. Overall, these data further suggest roles for BNST synaptic signaling in volitional ethanol intake that are partially independent of actions on affective behavior.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.52
- Field percentile
- top 40%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dopamine D2 receptors in the bed nucleus of the stria terminalis modulate alcohol-related behaviors.
Dipanwita Pati, Lisa R. Taxier, … Thomas L. Kash·Addiction NeurosciencePeer-reviewed·May 8, 2024
- Ethanol Self-Administration Reduces mGlu2/3 Protein Expression in the Nucleus Accumbens and mGlu2/3 Activation Suppresses Binge Drinking in Male Mice
Cassandra G. Modrak, Sarah E. Holstein, … Clyde W. Hodge·Alcoholism Clinical and Experimental ResearchPeer-reviewed·Sep 1, 2026
- Disentangling the effects of Corticotrophin Releasing Factor and GABA release from the ventral bed nucleus of the stria terminalis on ethanol self-administration in mice
Carol A. Gianessi, Harold L. Haun, … Thomas L. Kash·NeuropsychopharmacologyPeer-reviewed·Sep 6, 2025
- Operant alcohol self-administration targets GluA2-containing AMPAR expression and synaptic activity in the nucleus accumbens in a manner that drives the reinforcing properties of the drug
Sara Faccidomo, Briana L. Saunders, … Clyde W. Hodge·bioRxiv·Sep 13, 2024
- Estrogen Receptor α Regulates Ethanol Excitation of Ventral Tegmental Area Neurons and Binge Drinking in Female Mice
Bertha J. Vandegrift, Elisa R. Hilderbrand, … Amy W. Lasek·Journal of NeurosciencePeer-reviewed·Jun 1, 2020
- Bed Nucleus of the Stria Terminalis (BNST) neurons containing the serotonin 5HT2c receptor modulate operant alcohol self-administration behavior in mice
Meghan E. Flanigan, Carol A. Gianessi, … Thomas L. Kash·NeuropsychopharmacologyPeer-reviewed·Oct 26, 2023